CIK 0001385818
- Non-accelerated filer
- Smaller reporting company
AYTU BIOPHARMA, INC
Sign in to watch- Ticker
- AYTU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 470883144
- Phone
- +1 720-437-6580
- Business address
- 7900 E. UNION AVENUE, SUITE 920, DENVER, CO, 80237
- Former names
- AYTU BIOSCIENCE, INC, Rosewind CORP
- 4 Grant or award Director acquired 6,500 shares (grant or award)
- 4 Grant or award Director acquired 6,500 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 55,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,333,334 shares at $6.00 ($8,000,004)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 250,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 450,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 5,108,921 shares at $1.82 ($9,298,236)
- 4 Open-market sale 10% owner sold 92,777 shares at $1.55 ($144,092)
- 4 Other acquisition Director acquired 108,920 shares (other)
- 4 Open-market sale Director sold 22,026,801 shares at an average $1.42 ($31,200,123)
- 4 Other acquisition Director acquired 335,279 shares (other)
- 3 Insider Initial Statement of Ownership
Page 5 of 10 · 187 filings